Search: onr:"swepub:oai:gup.ub.gu.se/53925" >
Prostate cancer cel...
Prostate cancer cell lines lack amplification: overexpression of HER2
-
- Ullen, A. (author)
- Karolinska Institutet
-
Lennartsson, L. (author)
-
- Harmenberg, U. (author)
- Karolinska Institutet
-
show more...
-
- Lennernäs, Bo, 1963 (author)
- Gothenburg University,Göteborgs universitet,Institutionen för särskilda specialiteter, Avdelningen för onkologi,Institute of Selected Clinical Sciences, Department of Oncology
-
- Majumder, K. (author)
- Karolinska Institutet
-
Holmberg, A. R. (author)
-
- Nilsson, S. (author)
- Karolinska Institutet
-
Elmberger, G. P. (author)
-
show less...
-
(creator_code:org_t)
- 2009-07-08
- 2005
- English.
-
In: Acta Oncol. - : Informa UK Limited. - 0284-186X .- 1651-226X. ; 44:5, s. 490-5
- Related links:
-
https://gup.ub.gu.se...
-
show more...
-
https://doi.org/10.1...
-
http://kipublication...
-
show less...
Abstract
Subject headings
Close
- The potential overexpression of HER2 in prostate cancer cells has attended significant interest during the past few years, both as potential target for HER2 pathway focused therapy and as a mechanism involved in the progression to androgen independence. Conflicting results have been reported concerning HER2 status on clinical material, differences which generally have been attributed to methodological differences. Nevertheless, HER2 has been utilized for targeted therapy of prostate cancer in a number of preclinical studies and is still regarded as an exciting target molecule. In this study, the HER2 status of three widely used prostate cancer cell lines and corresponding xenografts has been analysed. By use of validated and FDA approved analytical staining techniques none of these cell lines or xenografts were shown to overexpress/amplify HER2, as demonstrated by immunohistochemistry and fluorescence in situ hybridization. These findings are important for the interpretation and understanding of the therapeutic effects when developing drugs targeting HER2 in prostate cancer cell lines and also emphasize the importance of using broad and validated analytical techniques.
Subject headings
- MEDICIN OCH HÄLSOVETENSKAP -- Klinisk medicin -- Cancer och onkologi (hsv//swe)
- MEDICAL AND HEALTH SCIENCES -- Clinical Medicine -- Cancer and Oncology (hsv//eng)
Keyword
- Animals
- Antibodies
- Monoclonal/diagnostic use
- Breast Neoplasms
- Male/genetics/metabolism
- Cell Line
- Tumor
- Gene Expression Regulation
- Neoplastic
- *Genes
- erbB-2
- Humans
- Immunohistochemistry
- In Situ Hybridization
- Fluorescence
- Male
- Mice
- Prostatic Neoplasms/*metabolism
- Receptor
- erbB-2/*biosynthesis
- Tumor Markers
- Biological/*metabolism
- Up-Regulation
Publication and Content Type
- ref (subject category)
- art (subject category)
Find in a library
-
Acta Oncol
(Search for host publication in LIBRIS)
To the university's database